Does CENEGERMIN-BKBJ Cause Hospitalisation? 247 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Hospitalisation have been filed in association with CENEGERMIN-BKBJ. This represents 2.1% of all adverse event reports for CENEGERMIN-BKBJ.
247
Reports of Hospitalisation with CENEGERMIN-BKBJ
2.1%
of all CENEGERMIN-BKBJ reports
13
Deaths
247
Hospitalizations
How Dangerous Is Hospitalisation From CENEGERMIN-BKBJ?
Of the 247 reports, 13 (5.3%) resulted in death, 247 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENEGERMIN-BKBJ. However, 247 reports have been filed with the FAERS database.
What Other Side Effects Does CENEGERMIN-BKBJ Cause?
Eye pain (5,847)
Eye irritation (1,871)
Product dose omission issue (1,335)
Ocular hyperaemia (1,226)
Photophobia (1,065)
Vision blurred (944)
Wrong technique in product usage process (899)
Eye swelling (847)
Ocular discomfort (797)
Lacrimation increased (737)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which CENEGERMIN-BKBJ Alternatives Have Lower Hospitalisation Risk?
CENEGERMIN-BKBJ vs CENOBAMATE
CENEGERMIN-BKBJ vs CEPHALEXIN
CENEGERMIN-BKBJ vs CERITINIB
CENEGERMIN-BKBJ vs CERLIPONASE ALFA
CENEGERMIN-BKBJ vs CERTICAN